BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 11513601)

  • 1. Real-time kinetics of ligand/cell surface receptor interactions in living cells: binding of epidermal growth factor to the epidermal growth factor receptor.
    Wilkinson JC; Stein RA; Guyer CA; Beechem JM; Staros JV
    Biochemistry; 2001 Aug; 40(34):10230-42. PubMed ID: 11513601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A stopped-flow fluorescence anisotropy method for measuring hormone binding and dissociation kinetics with cell-surface receptors in living cells.
    Wilkinson JC; Beechem JM; Staros JV
    J Recept Signal Transduct Res; 2002; 22(1-4):357-71. PubMed ID: 12503627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ErbB2 coexpression on the kinetic interactions of epidermal growth factor with its receptor in intact cells.
    Wilkinson JC; Staros JV
    Biochemistry; 2002 Jan; 41(1):8-14. PubMed ID: 11771997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of epidermal growth factor with its receptor in A431 cell membranes: a stopped-flow fluorescence anisotropy study.
    Rousseau DL; Staros JV; Beechem JM
    Biochemistry; 1995 Nov; 34(44):14508-18. PubMed ID: 7578056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analytical approach to the measurement of equilibrium binding constants: application to EGF binding to EGF receptors in intact cells measured by flow cytometry.
    Stein RA; Wilkinson JC; Guyer CA; Staros JV
    Biochemistry; 2001 May; 40(20):6142-54. PubMed ID: 11352752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells.
    Pierce JH; Ruggiero M; Fleming TP; Di Fiore PP; Greenberger JS; Varticovski L; Schlessinger J; Rovera G; Aaronson SA
    Science; 1988 Feb; 239(4840):628-31. PubMed ID: 3257584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
    EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand- and kinase activity-independent cell survival mediated by the epidermal growth factor receptor expressed in 32D cells.
    Ewald JA; Wilkinson JC; Guyer CA; Staros JV
    Exp Cell Res; 2003 Jan; 282(2):121-31. PubMed ID: 12531698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-dependent receptor/ligand dissociation as a determining factor for intracellular sorting of ligands for epidermal growth factor receptors in rat hepatocytes.
    Maeda K; Kato Y; Sugiyama Y
    J Control Release; 2002 Jul; 82(1):71-82. PubMed ID: 12106978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor contains both positive and negative determinants for interaction with ErbB-2/ErbB-3 heterodimers.
    Stortelers C; van De Poll ML; Lenferink AE; Gadellaa MM; van Zoelen C; van Zoelen EJ
    Biochemistry; 2002 Apr; 41(13):4292-301. PubMed ID: 11914075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate constants for binding, dissociation, and internalization of EGF: effect of receptor occupancy and ligand concentration.
    Waters CM; Oberg KC; Carpenter G; Overholser KA
    Biochemistry; 1990 Apr; 29(14):3563-9. PubMed ID: 2354152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system.
    Wiley HS
    J Cell Biol; 1988 Aug; 107(2):801-10. PubMed ID: 3262110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the transforming growth factor alpha B-loop beta-sheet to binding and activation of the epidermal growth factor receptor.
    Richter A; Drummond DR; MacGarvie J; Puddicombe SM; Chamberlin SG; Davies DE
    J Biol Chem; 1995 Jan; 270(4):1612-6. PubMed ID: 7829492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
    Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD
    Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-receptor interactions in the membrane of cultured cells monitored by fluorescence correlation spectroscopy.
    Pramanik A; Rigler R
    Biol Chem; 2001 Mar; 382(3):371-8. PubMed ID: 11347883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
    Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor.
    Odaka M; Kohda D; Lax I; Schlessinger J; Inagaki F
    J Biochem; 1997 Jul; 122(1):116-21. PubMed ID: 9276679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand induced internalization of epidermal growth factor receptors by A431 cells decreases at high cell densities in culture.
    Sunada H; Peacock J; Mendelsohn J
    Growth Factors; 1991; 5(1):45-55. PubMed ID: 1772661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid tyrosine kinase/cytokine receptors transmit mitogenic signals in response to ligand.
    Pacifici RE; Thomason AR
    J Biol Chem; 1994 Jan; 269(3):1571-4. PubMed ID: 8294397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescent-labeled growth factor molecules serve as probes for receptor binding and endocytosis.
    Carraway KL; Cerione RA
    Biochemistry; 1993 Nov; 32(45):12039-45. PubMed ID: 8218281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.